Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.
Författare
Summary, in English
Since treatment for latent cryptococcal infection (CI) before starting antiretroviral therapy (ART) reduces mortality in HIV-infected subjects, screening for cryptococcal antigen (CrAg) in blood is recommended for individuals with CD4 cell counts < 100 cells/µL in regions with high CI prevalence. We assessed CrAg screening using the lateral flow assay in HIV-infected adults eligible for ART in central Ethiopia.
Avdelning/ar
- Infectious Diseases Research Unit
- Klinisk mikrobiologi, Malmö
Publiceringsår
2015
Språk
Engelska
Publikation/Tidskrift/Serie
BMC Research Notes
Volym
8
Issue
1
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
BioMed Central (BMC)
Ämne
- Infectious Medicine
Status
Published
Forskningsgrupp
- Infectious Diseases Research Unit
- Clinical Microbiology, Malmö
ISBN/ISSN/Övrigt
- ISSN: 1756-0500